Day 2: Top Takeaways From ASCO24

Day 2: Top Takeaways From ASCO24

Up next

Expanding Treatment Options for Breast Cancer: ADCs and Oral SERDs

Dr. Monty Pal and Dr. Hope Rugo discuss advances in antibody-drug conjugates for various breast cancer types as well as treatment strategies in the new era of oral SERDs for HR-positive breast cancer. TRANSCRIPT Dr. Monty Pal: Hello, and welcome to the ASCO Daily News Podcast. I' ...  Show more

What Challenges Will Oncologists Face in 2026?

Dr. Monty Pal and Dr. Jason Westin discuss the federal funding climate for cancer research and the persistent problem of drug shortages, two of the major concerns facing the oncology community in 2026. TRANSCRIPT Dr. Monty Pal: Hello and welcome to the ASCO Daily News Podcast. I ...  Show more

Recommended Episodes

Review of the GISSI-2 Trial
Cardiology Trials

Lancet 1990;336:65-71.

Background Large trials up to this point had established the role of thr ...

  Show more

Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer
Clinical Conversations

A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE.

We’re back with another interview from this year’s IASLC conference.

This time, Christine Sadlowski and Dr. Julia Rotow interview Dr. Mar ...

  Show more

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2023.1 Part 2
ASCO Guidelines

Dr. Dwight Owen is back on the ASCO Guidelines podcast, discussing the latest updates to the ASCO living guidelines for stage IV NSCLC. In Part 2, Dr. Owen presents the update for stage IV NSCLC with driver alterations. He reviews new evidence from KRYSTAL-1, and reviews a new re ...  Show more

Podcast 831: O2 Targets
Emergency Medical Minute

Contributor: Aaron Lessen,MD

Educational Pearls:

<ul> <li style="font-weight: 400;" aria-level="1"><span style= "font-weight: 400;">R</span><span style="font-weight: 400;">ecent study looked at mechanically ventilated patients in ED ...  Show more